Beat The Overvalued S&P 500 On August 24, 2021, Chuck Carnevale, Co-Founder of FAST Graphs, a.k.a. Mr. Valuation, built three portfolios for dividend income with different objectives. In this video, Part 3, Chuck will do an update on Model Portfolio Number 3 to see how it’s performed against the S&P 500. The portfolio was to …
Cardinal Health (CAH)
Update Model Portfolio No. 2 That Beat The Overvalued S&P 500 (Part 2 of 3)
The Overvalued S&P 500 On August 24, 2021, Chuck Carnevale, Co-Founder of FAST Graphs, a.k.a. Mr. Valuation, built three portfolios for dividend income with different objectives. In this video, Chuck will do an update on dividend Model Portfolio Number 2 to see how it’s performed. Model 2 is more oriented toward future yield and future …
Secret Recipe That Beat The Overvalued S&P 500 – Update Model Portfolio 1 – (Part 1 of 3)
Beat the Overvalued S&P 500 – Reviewing Model Portfolio 1 from Aug 20, 2021 In this video Chuck Carnevale, Co-Founder of FAST Graphs, a.k.a. Mr. Valuation is going to share a surefire method or strategy to beat the overvalued S&P 500 in both a total income basis as well as a total return basis. Chuck …
14 Stocks in the Healthcare Sector | FAST Graphs
Healthcare Sector This is the 6th in a series of 11 videos where I will cover each of the 11 sectors looking for value. There are somewhere between 18,000 to 20,000 stocks comprising the US and Canadian stock markets. With this series I have screened for investment-grade stocks in each sector that appear to be …
40 Consistent Attractively Valued Dividend Growth Stocks
Dividend Growth Stocks I am constantly being asked to provide a list of high-quality consistent dividend growth stocks. Consequently, I conducted a search and came up with 40 dividend growth stocks that I feel are worthy of further research and due diligence. These companies have consistent long-term operating history and solid prospects for future growth. …
Owens & Minor: A Treacherous Path To 10% Returns
Introduction On January 26, 2018, I wrote an article titled: “Owens & Minor Inc.: Irresistible Yield, Irresistible Valuation” where I offered the company as an extremely undervalued Dividend Contender research candidate. I also pointed out that the company was in transformation. However, I underestimated what that transformation meant, at least over the short run. I …
Cardinal Health Update-A Dividend Aristocrat on Sale
Introduction On November 22, 2017, I published an article titled: “Cardinal Health: A Dividend Aristocrat the Risk Is Already Priced In.” At that time, Cardinal Health (CAH) was trading at approximately $56 per share and was paying a dividend of $1.81 representing a dividend yield of about 3.1%. Of course, a lot has changed with …
The S&P 500 is Overvalued These 10 Dividend Growth Stocks Are Not: Part 3
Introduction This is the third of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value. With this article I will be covering 10 additional dividend growth research candidates with moderate to higher yields in addition to the initial 20 that I presented in part 1 found here and …